BASF reported Q1 2026 EBITDA before special items of €2.4bn, down 6% year-on-year, with cash fixed costs at €3.9bn down 5% and €1.9bn of annualised run-rate savings toward the €2.3bn target1. The German chemical major warned prevailing gas prices were unsustainable for European operations and flagged Verbund site production freezes as a contingent option. EBITDA before special items is earnings before interest, tax, depreciation, amortisation and one-off charges; the Verbund is BASF's integrated production network where ammonia, ethylene and acetylene compete for the same pipeline gas.
The corporate read tracks the same cost mechanism running through Yara's simultaneous 25% March curtailment. BASF's hedge book runs through long-term supply contracts, but spot exposure on the marginal molecule sets the variable cost line that decides whether a plant runs. At €47 spot the marginal Verbund unit clears below cash-cost, with TTF still sitting within the €43-47 band held since the start of May.
The simultaneity with Yara's curtailment confirms this is a sector-wide read, not a company-specific shock. Cefic's running tally of European chemicals capacity contraction accumulates a fresh quarterly print on both companies; the European chemical fleet faces structural pressure on a marginal-cost basis that long-term contracts cannot fully insulate. Verbund site freezes would remove integrated chemical chains from the European supply base, with knock-on effects on automotive, packaging and pharmaceuticals.
The Q1 guidance cut and the contingent freeze flag are the operational data point for procurement desks tracking demand destruction. BASF's 2026 closure flags are running on a TTF print roughly €23 below the 2022 ceiling, without a single supply event needed to deliver them. Industrial workers in chemicals face renewed restructuring exposure, particularly at integrated Verbund sites where the marginal molecule sets the cash-cost line.
